News Release
Vodis Pharma submits confirmation of readiness package
2018-11-27 10:03 ET - News Release
Dr. Earl Oliver reports
VODIS COMPLETES HEALTH CANADA CONFIRMATION OF READINESS EVIDENCE PACKAGE
Vodis Pharmaceuticals Inc. has completed and submitted to Health Canada its confirmation of readiness evidence package for a licence under the cannabis regulations. The evidence package is a comprehensive set of reports, photos and videos that detail the good production practices and security measures in place at the company's Delta, B.C., facility. Submission of the confirmation of readiness evidence package is the final stage before obtaining a cultivation licence from Health Canada.
Dr. Earl Oliver states: "The package provides conclusive evidence that the company's Delta facility is ready to produce cannabis in accordance with the highest security and production quality standards. The package is primarily concerned with the physical security measures in place at the facility. The facility's security measures meet, and in many cases exceed, the current requirements under the cannabis regulations. No detail of the evidence package has been omitted to ensure the issuance of a licence from Health Canada."
The company is also pleased to report that on Nov. 7, 2018, Health Canada introduced a series of transitional measures to fast-track late-stage applicants through the licencing process. Vodis is among the set of late-stage applicants to benefit from the transitional measures.
The company is announcing the resignation of Mr. Ovagemov from the board of directors. Under Section 50(b) of the cannabis regulations that came into effect on Oct. 17, 2018, all directors and officers of a controlling parent company must hold a valid security clearance from Health Canada. The company asked Mr. Ovagemov, a non-Canadian resident, to resign his position on the board of directors to avoid unnecessary delays in obtaining licences from Health Canada. Mr. Ovagemov will remain as a member of the company's board of advisers until the necessary security clearances have been obtained. Mr. Ovagemov will also remain as a director of the company's subsidiary, Vodis USA Inc.
About Vodis Pharmaceuticals Inc.
Vodis is one of North America's foremost brand names in the medical and recreational marijuana business with operations in both the United States and Canada. Its master grow teams have consistently won or placed at each Canadian competition they have entered with their VIP brand. The company, with facilities in British Columbia and Washington, is also actively looking into expansion opportunities in other countries and throughout the United States.
We seek Safe Harbor.